Literature DB >> 2916029

Tantalum vascular stents: in vivo evaluation with MR imaging.

A H Matsumoto1, G P Teitelbaum, K H Barth, M J Carvlin, M A Savin, E P Strecker.   

Abstract

Magnetic resonance (MR) imaging at 1.5 T was performed on tantalum vascular stents placed in the aortas of six dogs. The stents produced no significant artifact and allowed for clear depiction of the aortic lumina as flow-void zones with spin-echo imaging and as high-signal areas with gradient-echo imaging. The MR findings correlated with the angiographic studies of the stented vessels. These results demonstrate the feasibility of MR imaging as a noninvasive means of evaluating vessel patency in the presence of tantalum vascular stents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916029     DOI: 10.1148/radiology.170.3.2916029

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  The Strecker stent: indications and results in iliac and femoropopliteal arteries.

Authors:  D Liermann; E P Strecker; J Peters
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Magnetic resonance angiography of intravascular endoprostheses: investigation of three devices.

Authors:  J P Laissy; C Grand; C Matos; J Struyven; J F Berger; E Schouman-Claeys
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

3.  Iliac and femoropopliteal vascular occlusive disease treated with flexible tantalum stents.

Authors:  E P Strecker; B Hagen; D Liermann; B Schneider; H R Wolf; J Wambsganss
Journal:  Cardiovasc Intervent Radiol       Date:  1993 May-Jun       Impact factor: 2.740

4.  CT and MR imaging findings and their implications in the follow-up of patients with intracranial aneurysms treated with endosaccular occlusion with onyx.

Authors:  Isil Saatci; H Saruhan Cekirge; Elisa F M Ciceri; Michel E Mawad; A Gulsun Pamuk; Aytekin Besim
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.